Chronic Lymphocytic Leukemia Therapeutics Market Checkout the Unexpected Future 2026 : Novartis, GlaxoSmithKline, Biogen Idec, AstraZeneca Plc
Chronic lymphocytic leukemia (CLL) is one of the most common type of leukemia found in adults. It is a type of tumor, which is characterized by production of abnormal white blood cells in the bone marrow. Its symptoms are swelling of the lymph nodes, fatigue, fever, infection, pain beneath the ribs, and weight loss. Moreover, CLL is seldom observed in children and people aged 40 years and below, as it is more prevalent in geriatric population. Moreover, its causes unknown...
View full press release